Hosted by: Sartorius
Published: 20.08.2024. - 14:41
When it comes to the commercialization of biologics, efficient and high-quality cell line development (CLD) is crucial for success. Some companies have extensive in-house capabilities and seek reliable equipment suppliers to help guide early-stage development and ensure a smooth transition to manufacturing. On the other hand, certain companies need a fully external solution for cell line development and experienced experts to oversee the entire CLD project. Others require a hybrid approach for a customized CLD solution that best meets their needs.
The common link in each scenario is the need for a reliable partner who offers experience, expertise, and a comprehensive portfolio of products and services to minimize risks and optimize outcomes. Christoph Zehe will highlight the key challenges of biopharmaceutical cell line development and how synergy with a single supplier increases efficiency and reduces project management demands and overall costs.
Key insights:
Agenda for this event is not yet available.
Online